Evidence map›Paper›PMID 25592613›Full record

ArticleJapanese journal of ophthalmology2015

Virological and molecular biological evidence supporting herpes simplex virus type 1 corneal latency.

Shiro Higaki, Masahiko Fukuda, Yoshikazu Shimomura

Abstract read
PubMed Publisher
In one paragraph

Article in Japanese journal of ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shiro HigakiDepartment of Ophthalmology, Kinki University Sakai Hospital, 2-7-1 Harayamadai, Minami Ward, Sakai, Osaka, 590-0132, Japan, higaki@sakai.med.kindai.ac.jp.
Masahiko Fukuda
Yoshikazu Shimomura

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTrigeminal and other ganglia are known as sites of latent infection by herpes simplex virus type 1 (HSV-1). In ophthalmology, HSV-1 remains latent in the trigeminal ganglia, and becomes reactivated by several factors, including stress, thermal stimulation, or immunosuppression, and may lead to herpetic keratitis. The purpose of this study was to demonstrate HSV corneal latent infection using molecular biology and virology techniques.

methodsSix corneas obtained at penetrating keratoplasty were snap-frozen; three of them were with past history of herpetic keratitis. TaqMan Real-time PCR was used to show positive HSV DNA in the corneas. We proved negative homogenate and positive explant virologically. Using real-time RT-PCR, we showed that only latency-associated transcript (LAT) was detected and no transcriptional products of other virus genes (α, β, γ) were detected.

resultsAll three corneas with past history of herpetic keratitis had HSV DNA and showed negative homogenate and positive explant. LAT was detected in all three corneas. However, α, β, or γ genes were not expressed. All the results of these corneas were consistent with the conditions of corneal latency. The other three corneas without history of herpetic keratitis showed negative homogenate and negative explant. None of them had LAT.

conclusionWe have shown a possibility that HSV can latently infect the cornea aside from the ganglion.

Indexed as

CorneaDNA, ViralGene Expression Regulation, ViralHerpesvirus 1, HumanHumansKeratitis, HerpeticKeratoplasty, PenetratingMicroRNAsReal-Time Polymerase Chain ReactionTrigeminal GanglionVirus ActivationVirus LatencyDNA, Virallatency associated transcript, herpes simplex virus-1MicroRNAs

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.